AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Phase III clinical program initiated for Atamestane.(Brief Article)

Women's Health Weekly

| September 19, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 SEP 19 - (NewsRx.com & NewsRx.net) -- BioMedicines, Inc., announced that it has enrolled the first patients in its phase III clinical trial of Atamestane.

In this randomized, double-blind, placebo-controlled study, Atamestane will by administered as part of a two-drug combination hormonal therapy to treat women with metastatic breast cancer. To date, BioMedicines has qualified clinical sites in the United States, Canada, Russia, and the Ukraine.

"Our goal is to introduce a new standard of care for these patients," said Peter Langecker, MD, PhD, vice president of clinical affairs. "This study is designed to demonstrate that our Atamestane combination therapy is superior to current hormonal monotherapy."

Atamestane is an experimental drug that inhibits the growth of estrogen-dependent ...

Related articles from newspapers, magazines, journals, and more
Phase III clinical program initiated for Atamestane.
Newspaper article from: Biotech Week September 18, 2002 700+ words
...first patients in its phase III clinical trial of Atamestane. In this randomized...hormonal monotherapy." Atamestane is an experimental...estrogen synthesis. Atamestane will be used in conjunction...the basis for our phase III study and new intellectual...
INTARCIA RAISES $50M VIA SERIES E FOR ATAMESTANE.(Intarcia Therapeutics Inc....
Magazine article from: BIOWORLD Today Pihl-Carey, Karen December 2, 2004 700+ words
...us to continue our Phase III program for Atamestane and allow us to move...patients indicate Atamestane is well tolerated...The compound entered Phase III testing in the U...to demonstrate that Atamestane in combination with...
Phase III Medical Announces Appointment of Harvard's Dr. Wayne Marasco as...
Press release article from: Business Wire November 23, 2004 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM...Marasco joined the Board of Directors of Phase III Medical in June 2003. He is an Associate...biographical information on Dr. Marasco and Phase III Medical, please refer to the Company...
Neurocrine Biosciences Ramps Up Phase III Clinical Trials for NBI-34060 In...
Press release article from: PR Newswire March 19, 2002 700+ words
...is initiating three additional pivotal Phase III clinical trials of NBI-34060 Immediate...1200 patients. The Company's first Phase III study with NBI-34060-IR was previously...currently be conducting four of eight planned Phase III clinical trials with NBI-34060. According...
CMS Releases Stark Phase III Regulations.(United States. Centers for Medicare...
News wire article from: Mondaq Business Briefing September 4, 2007 700+ words
...copy of the long-awaited Stark II Phase III Regulations. Overall, healthcare providers should be pleased with the Phase III Stark rules. Despite fears that...would be drastically altered, the Phase III revisions are for the most part...
Phase III Medical Completes Acquisition of NeoStem, Inc., an Adult Stem Cell...
Press release article from: Business Wire January 26, 2006 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (Phase III) (OTCBB:PHSM), has completed the acquisition of...stem cells. Pursuant to the terms of the acquisition, Phase III, through its wholly owned subsidiary, has purchased...
Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache...
Press release article from: Business Wire September 11, 2008 700+ words
-- Phase III Studies Show Statistically Significant...completed a top-line analysis of its two Phase III clinical trials exploring the use of...pleased with the top-line results of our Phase III clinical trials which show that BOTOX...
Pain Therapeutics Completes Patient Enrollment for Phase III Study with...
Press release article from: PR Newswire September 8, 2004 700+ words
...successfully completed enrollment in a Phase III study of over 700 patients with severe...delighted patient enrollment for this pivotal Phase III study is on-time and on-budget...or osteoarthritic pain. Oxytrex is in Phase III clinical studies. What is Our Clinical...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA